Perspectives in pancreatic and islet cell transplantation for the therapy of IDDM

Diabetes Care

Volumn 20, Issue 5, 1997, Pages 889-896

  Calafiore, Riccardo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETES MELLITUS; ENDOCRINE SURGERY; GRAFT SURVIVAL; HUMAN; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0030917905     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.20.5.889     Document Type: Review

References (62)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:976-986, 1993
2. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P, Porcellati F, Scionti L, Santeusanio F, Brunetti P, Bolli GB: Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitudes of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term diabetes. Diabetes 42:1683-1689, 1993
3. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, Di Vincenzo A, Epifano L, Ciofetta M, Pampanelli S, Brunetti P, Bolli GB: Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue (Lys-B28, Pro-B29) in IDDM. Diabetologia 37:713-720, 1994
4. The Diabetes Control and Complications Trial Research Group: The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes 45:1289-1298, 1996
5. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH: Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255, 1995
6. Sutherland DER, Gruessner A: Pancreas transplant results in United Network for Organ Sharing (UNOS) United States of America Registry with a comparison to non-USA data in the International Registry. In Clinical Transplants. Terasaki PI, Ed. Los Angeles, CA, UCLA Tissue Typing Laboratory, 1995, p. 49-67
7. Sollinger HW, Geffner SR: Pancreas transplantation. Surg Clin North Am 74:1183-1195, 1994
8. Stratta RJ, Taylor RJ, Larsen JL, Cushing K: Pancreas transplantation. Ren Fail 17:323-337, 1995
9. Douzdjian V, Rice JC, Gigliuzza KK, Fish JC, Carson RW: Renal allograft and patient outcome after transplantation: pancreas-kidney versus kidney-alone transplants in type 1 diabetic patients versus kidney-alone transplants in nondiabetic patients. Am J Kidney Dis 27:106-116, 1996
10. Remuzzi G, Ruggenenti P, Mauer SM: Pancreas and kidney/pancreas transplants: experimental medicine or real improvement? Lancet 343:27-31, 1994
11. Sutherland DER: The case for pancreas transplantation. Diabete Metab 22:132-138, 1996
12. Sibley RK, Sutherland DER, Goetz F, Michael H: Recurrent diabetes mellitus in the pancreas iso-and allograft: a light and electron microscopy immunohistochemical analysis of four cases. Lab Invest 53:132-144, 1985
13. Tyden G, Reinholt FP, Sundkvist G, Bolinder J: Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts. N Engl J Med 335:860-863, 1996
14. Eisenbarth GS, Stegall M: Islet and pancreatic transplantation: autoimmunity and alloimmunity. N Engl J Med 335:888-889, 1996
15. Rooney DP, Robertson RP: Hepatic insulin resistance after pancreas transplantation in type 1 diabetes. Diabetes 45:134-138, 1996
16. Gruessner RW, Sutherland DER: Simultaneous kidney and segmental pancreas transplants from living related donors: the first two successful cases. Transplantation 61:1265-1268, 1996
17. Lacy E, Kostianovsky M: Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16:35-39, 1967
18. Gray DWR, McShane P, Grant AM, Morris PJ: A method for isolation of islets of Langerhans from the human pancreas. Diabetes 33:1055-1061, 1984
19. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW: Automated method for isolation of human pancreatic islets. Diabetes 37:413-420, 1988
20. Warnock GL, Tsapogas P, Ryan FA, Lakey JR, Korbutt G, Kneteman NM, Ao Z, Rabinovitch A, Rajotte RV: Natural history of insulin-independence after transplantation of multidonor cryopreserved pancreatic islets in type 1 diabetic humans. Transplant Proc 27:3159-3160, 1995
21. Hering BJ, Bretzel RG, Hopt UT, Brandhorst H, Brandhorst D, Bollen CC, Raptis G, Helf F, Grossman R, Mellert J: New protocol toward prevention of early human islet allograft failure. Transplant Proc 26:570-571, 1994
22. Socci C, Falqui L, Davalli AM, Ricordi C, Braghi S, Bertuzzi F, Maffi P, Secchi A, Gavazzi F, Fresch M, Magistretti P, Socci S, Vignali A, Di Carlo V, Pozza G: Fresh human islet transplantation to replace pancreatic endocrine function in type I (insulin-dependent) diabetes mellitus. Diabetologia 34:55-58, 1991
23. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC: Vulnerability of islets in the immediate posttransplantation period: dynamic changes in structure and function. Diabetes 19:1161-1167, 1996
24. Brunicardi FC, Stagner J, Bonner-Weir S, Wayland H, Kleinman R, Livingston E, Guth P, Menger M, McCuskey R, Intaglietta M, Charles A, Ashley S, Cheung A, Ipp E, Gilman S, Howard T, Passaro E: Microcirculation of the islets of Langerhans. Diabetes 45:385-392, 1996
25. Samols E, Stagner JI: Intraislet and islet-acinar portal systems and their significance. In The Endocrine Pancreas. Samols E, Ed. New York, Raven, 1993, p. 759-768
26. Williams A, Goldfine ID: The insulin-pancreatic acinar axis. Diabetes 34:980-986, 1985
27. Kaufman DB, Morel P, Field MJ: Purified canine islet autografls: functional outcome as influenced by islet number and implantation site. Transplantation 50:385-391, 1990
28. Wahoff DC, Papalois BE, Najarian JS, Kendall DM, Famey AC, Leone JP, Jessurin J, Dunn DL, Robertson RP, Sutherland DER: Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 222:562-575, 1995
29. Rosenberg L, Vinik AI, Pittenger GL, Rafaeloff R, Duguid WP: Islet-cell regeneration in the diabetic hamster pancreas with restoration of normoglycemia can be induced by local growth factors. Diabetologia 39:256-262, 1996
30. Hayek A, Beattie GM, Cirulli V, Lopez AD, Ricordi C, Rubin JS: Growth factor/matrix-induced proliferation of human adult β-cells. Diabetes 44:1458-1460, 1996
31. Beattie GM, Rubin JS, Mally MI, Otolonski T, Hayek A: Regulation of proliferation and differentiation of human fetal pancreatic islets by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes 45:1223-1228, 1996
32. Hering BJ, Browatzki CC, Schultz AO, Bretzel RG, Federlin K: Transplant Registry report on adult and fetal islet allografts. Transplant Proc 26:565-568, 1994
33. Rajotte RV, Lakey JRT, Warnock GL: Adult islet cryopreservation. In Methods in Cell Transplantation. Ricordi C, Ed. New York, Landes RG, 1995, p. 517-524
34. Lakey JRT, Wamock GL, Ao Z, Rajotte RV: Bulk cryopreservation of isolated islets of Langerhans. Cell Transplant 5:395-404, 1996
35. Warnock GL, Kneteman NM, Ryan NM: Normoglycemia after transplantation of freshly and cryopreserved pancreatic islets in type I (insulin-dependent) diabetes mellitus. Diabetologia 34:55-58, 1991
36. Basta G, Falorni A, Osticioli L, Brunetti P, Calafiore R: Method for mass retrieval, morphologic and functional characterization of adult porcine islets of Langerhans: a potential nonhuman pancreatic tissue resource for xenotransplantation in insulin-dependent diabetes mellitus. J Invest Med 43:555-566, 1995
37. Marchetti P, Giannarelli R, Cosimi S, Masiello P, Coppini A, Viacava P, Navalesi R: Massive isolation, morphologic and functional characterization, and xenotransplantation of bovine pancreatic islets. Diabetes 44:375-381, 1995
38. Newgard CB: Cellular engineering for the treatment of metabolic disorders: prospects for therapy in diabetes. Biotechnology 10: 1112-1120, 1992
39. Poitut V, Stout LE, Armstrong MB, Walseth TF, Sorenson RL, Robertson RP: Morphological and functional characterization of β-TC-6 cells: an insulin-secreting cell line derived from transgenic mice. Diabetes 44:306-313, 1995
40. Gores PF, Sutherland DER: Immunosuppression for islet transplantation. In Pancreatic Islet Transplantation. Vol. II. Lanza RP, Chick WL, Eds. Austin, TX, Landes RG, 1994, p. 63-74
41. International Islet Transplantation Registry Newsletter on 15th Artificial Insulin Delivery Systems Pancreas and Islet Transplantation, European Study Group Meeting, Igls, Austria, 1996
42. Goss JA, Finke EH, Flye MW, Lacy PE: Induction of immune unresponsiveness to concordant islet xenografts by intrahepatic preimmunization and transient immunosuppression. J Clin Invest 93:1312-1314, 1994
43. Posselt AM, Barker CF, Tomaszewski JA, Markman JF, Choti MA, Naji A: Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science 249:1293-1295, 1990
44. Goss JA, Nakafusa Y, Flye MW: Intrathymic injection of donor alloantigen induces specific tolerance to cardiac allografts. Transplantation 56:166-173, 1993
45. Fontes P, Rao A, Demetris AJ, Zeevi A, Trucco M, Carroll P, Rybka W, Ricordi C, Dodson F, Shapiro R, Tzakis A, Todo S, Abu-Elgmad K, Jordan M, Fung JJ, Starzl TE: Augmentation with bone marrow of donor leukocyte migration for kidney, liver, heart and pancreas islet transplantation. Lancet 344:151-155, 1994
46. Lacy PE, Davie JM, Finke EH: Prolongation of islet allograft survival following in vitro culture (24C) and single injection of ALS. Science 204:312-313, 1979
47. Lafferty K, Cooley MA, Woolnough J: Thyroid allograft immunogenicity is reduced after a period in organ culture. Science 188:259-261, 1975
48. Hardy MA, Oluwole SF: Effect of ultraviolet radiation on immunogenicity of tissues and organ allografts. Transplant Rev 5:46-62, 1991
49. Faustman D: Antibodies directed to MHC determinants for transplantation. In Pancreatic Islet Transplantation. Vol. II. Lanza RP, Chick WL, Eds. Austin, TX, Landes RG, 1994, p. 129-139
50. Lanza RP, Sullivan SJ, Chick WL: Islet transplantation with immunoisolation. Diabetes 41:1503-1510, 1990
51. Colton CK: Implantable biohybrid artificial organs. Cell Transplant 4:415-436, 1995
52. Scharp DW, Swanson CJ, Olack BJ, Latta PP, Hegre OD, Doherty EJ, Gentile FT, Flavin KS, Ansara MF, Lacy PE: Protection of encapsulated human islets implanted without immunosuppression in patients with type 1 or type II diabetes and nondiabetic control subjects. Diabetes 43:1167-1170, 1994
53. Maki T, Otsu I, O'Neill JJ, Dunleavy K, Mullon CJP, Solomon BA, Monaco AP: Treatment of diabetes by xenogeneic islets without immunosuppression: use of a vascularized bioartificial pancreas. Diabetes 45:342-347, 1996
54. Lim F, Sun AM: Microencapsulated islets as bioartificial endocrine pancreas. Science 210:908-910, 1980
55. Calafiore R, Basta G: Microencapsulation of pancreatic islets: theoretical principles, technologies and practice. In Methods in Cell Transplantation. Ricordi C, Ed. New York, Landes RG, 1995, p. 587-609
56. Lum ZP, Tai IT, Krestow M, Norton J, Vacek I, Sun AM: Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 40:1511-1516, 1991
57. Soon-Shiong P, Feldman E, Nelson R, Komtedebbe J, Smidsrod O, Skjak-Braek G, Espevik T, Heintz R, Lee M: Successful reversal of spontaneous diabetes in dogs by intraperitoneal microencapsulated islets. Transplantation 54:769-774, 1992
58. Soon-Shiong P, Heintz R, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R, Mendez R, Sanford PA: Insulin independence in a type I diabetic patient after encapsulated islet transplantation. Lancet 343:950-951, 1994
59. Calafiore R, Basta G, Falorni A, Brotzu G, Alfani D, Cortesisni R, Brunetti P: Vascular graft of microencapsulated human pancreatic islets in nonimmunosuppressed diabetic recipients: preliminary results. Diab Nutr Metab 4:45-48, 1991
60. Gill R, Wolf L: Immunobiology of cellular transplantation. Cell Transplant 4:361-370, 1995
61. Basta G, Osticioli L, Rossodivita ME, Sarchielli P, Tortoioli C, Brunetti P, Calafiore R: Method for fabrication of coherent microcapsules: a new potential immunoisolatory barrier for pancreatic transplantation. Diab Nutr Metab 8:105-112, 1995
62. Calafiore R, Basta G, Osticioli L, Luca G, Tortoioli C, Brunetti P: Coherent microcapsules for pancreatic islet transplantation: a new potential approach for bioartificial pancreas. Transplant Proc 28:822-823, 1995